Compare Mounjaro And Wegovy: Clinical Mechanisms Explained
Understanding The Difference Between Mounjaro And Wegovy Mechanisms
The fundamental difference between Mounjaro and Wegovy lies in their molecular mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, which works as a dual agonist targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously.
This dual-pathway approach means Mounjaro affects both incretin hormone systems involved in blood sugar control and appetite regulation, whilst Wegovy focuses specifically on the GLP-1 pathway. Both treatments are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity. Your prescriber at EverydayMeds can evaluate which mechanism may be more suitable based on your individual medical history and treatment goals.
Pricing Differences Between Mounjaro And Wegovy At EverydayMeds
Understanding the cost difference between Mounjaro and Wegovy helps inform your treatment decision. Wegovy pricing starts with 0.25mg pens at £79.99 (using discount code FIRST40), progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance dose 2.4mg at £209.99. Our Getting Started bundles provide convenience, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, covering your first two months.
We also offer 3-pen bundles for extended supply security, including the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, providing your complete dose escalation sequence. Returning customers benefit from discount code DOSE25 applied at checkout. All prices include prescriber review, clinical assessment, and next-day cold-chain delivery from our GPhC-registered pharmacy (#9012878). Both Wegovy and Mounjaro are available through the same streamlined ordering process.
Clinical Evidence: What The Difference Between Mounjaro And Wegovy Shows
The clinical evidence base demonstrates distinct profiles for each treatment, though direct head-to-head comparisons aren't available due to different trial designs and populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks, as reported by Wilding et al., NEJM, 2021. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events among patients using semaglutide.
Mounjaro's clinical evidence comes from the SURMOUNT trial programme, showing efficacy in weight management through its dual incretin pathway approach. Both treatments have demonstrated their effectiveness when used as prescribed alongside lifestyle modifications. Your clinical assessment will consider these evidence bases alongside your individual health profile to determine the most appropriate treatment option through our comprehensive prescriber review process.
How Wegovy Works: The Difference Between Mounjaro And Wegovy Action
Wegovy functions as a GLP-1 receptor agonist, closely mimicking the action of your body's natural incretin hormone GLP-1. When injected once weekly, semaglutide binds to GLP-1 receptors in your brain's appetite control centres, sending signals that reduce hunger and increase feelings of fullness after eating. This mechanism helps you feel satisfied with smaller portions and may reduce food cravings throughout the day. The treatment works gradually, which is why the dosing schedule starts at 0.25mg and escalates over 16 weeks to the maintenance dose of 2.4mg. This approach allows your body to adjust to the medication whilst minimising potential side effects during the initial treatment period.
Ordering Process: Getting Started With Either Treatment
The ordering process for both Wegovy and Mounjaro follows the same streamlined pathway at EverydayMeds. You'll complete a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers then review your assessment, typically within 3 working days (or 24 hours with express service). Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy and dispatched via next-day cold-chain delivery to maintain the required temperature throughout transit. All communication regarding your treatment happens through your secure patient portal, ensuring privacy and continuity of care.
Storage Advantages: Key Practical Difference Between Mounjaro And Wegovy
One significant practical difference between Mounjaro and Wegovy relates to storage flexibility, particularly important for travel or lifestyle considerations. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, whilst Mounjaro pens should only be kept at room temperature for up to 21 days. Both treatments require refrigerated storage at 2-8°C before first use and utilise easy-to-use pre-filled FlexTouch injection pens. This storage advantage makes Wegovy more suitable for extended travel periods or situations where consistent refrigeration access might be challenging. The dose escalation schedule is mandatory for both treatments, starting low and gradually increasing to minimise side effects whilst building therapeutic effectiveness.
Prescription Weight Loss: Why The Difference Between Mounjaro And Wegovy Matters
The choice between Mounjaro and Wegovy represents a significant decision in your prescription weight loss journey, as each treatment offers distinct advantages depending on your individual circumstances. Wegovy's established clinical evidence base, superior storage flexibility, and focused GLP-1 mechanism make it an excellent choice for many patients beginning their weight management journey. The treatment is NICE-recommended (TA875) and has demonstrated sustained effectiveness in long-term studies.
Mounjaro's dual incretin pathway approach may appeal to patients seeking a different mechanism of action, particularly those with specific metabolic considerations. Both treatments are subject to MHRA additional monitoring (Black Triangle ▼) and require ongoing clinical supervision. The decision ultimately depends on your individual medical profile, lifestyle requirements, and prescriber recommendation following comprehensive assessment.
Start Your Prescription Weight Loss Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds through our regulated, professional service that prioritises your safety and treatment success. New customers can use discount code FIRST40, whilst returning customers benefit from DOSE25, both applied at checkout. Our clinical team provides ongoing support throughout your treatment journey, ensuring you receive appropriate monitoring and guidance. The 3-minute online assessment can be completed today, with prescriber review typically completed within 3 working days. Take the first step towards effective prescription weight loss treatment by choosing the option that aligns with your individual needs and circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
